Veracyte, Inc. (VCYT) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Veracyte, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.480 Good day and thank you for standing by. Welcome to the VeriCite second quarter 2025 00:00:05.480 -- 00:00:10.860 financial results webcast. At this time, all participants are in a listen only mode. 00:00:10.860 -- 00:00:14.800 After the speaker's presentation, there will be a question and answer session. 00:00:14.800 -- 00:00:19.340 To ask a question during this session, you'll need to press star one one on your telephone. 00:00:19.340 -- 00:00:22.600 You will then hear an automated message advising your hand is raised. 00:00:22.600 -- 00:00:26.700 To withdraw your question, please press star one one again. 00:00:26.700 -- 00:00:29.720 Please be advised that today's conference is being recorded. 00:00:29.720 -- 00:00:34.620 I would now like to hand the conference over to your first speaker for today, Shayla 00:00:34.620 -- 00:00:35.160 Gorman. 00:00:35.160 -- 00:00:35.560 Please 00:00:35.420 -- 00:00:37.680 go ahead. 00:00:37.860 -- 00:00:41.740 Good afternoon, everyone, and thank you for joining us today for a discussion of our 00:00:41.740 -- 00:00:46.860 second quarter 2025 financial results. With me today are Mark Staffley, 00:00:46.860 -- 00:00:51.940 VeriCite's chief executive officer, and Rebecca Chambers, our chief financial officer. 00:00:51.940 -- 00:00:54.800 Dr. John Lay, our chief commercial officer, and Dr. 00:00:54.800 -- 00:01:00.060 Phil Febo, our chief medical and scientific officer will join us for Q&A. 00:01:00.060 -- 00:01:04.560 VeriCite issued a press release earlier this afternoon, detailing our second quarter 00:01:04.560 -- 00:01:09.780 2025 financial results. This release and a copy of the presentation we 00:01:09.780 -- 00:01:14.280 will review during the call today are available in the investor section ...